The FDA has a approved a new drug to treat a rare and aggressive form of multiple sclerosis. Who should take the drug and what is the cost?

Results of a new trial suggest that certain probiotics can improve mental health, metabolic function, and disability among individuals with multiple sclerosis. This study is just one of several that has explored the impact of beneficial bacteria on the symptoms and progression of multiple sclerosis.

Previous research has suggested a link between obesity and an increased risk of multiple sclerosis, but some experts have questioned the validity of those findings because of bias related to study design. Now a new study has clarified the association between obesity and MS risk, using a model shown to significantly minimize bias and establish causality.

The findings of a systematic review indicate that adolescent obesity could be a risk factor for multiple sclerosis. If future research supports this idea, it “would be of major significance,” according to experts at the University of British Columbia, especially given the rising number of children and adolescents who are overweight or obese.

Some people with multiple sclerosis decide to avoid yoga because they believe they won’t be able to do the poses or may feel embarrassed if they can’t keep up with others in the class. However, fortunately there is adaptive yoga for multiple sclerosis, which can make this beneficial form of exercise available to just about anyone.

Hematopoietic stem cell transplantation, which is commonly used for patients with blood and bone marrow cancers, has been the focus of several studies for people who have multiple sclerosis. Now a new report from an Australian team offers some insight into this treatment approach, including which MS patients seem to be the most likely to benefit from it.

A new study suggests that commonly used food additives in processed foods could play a significant role in the development of multiple sclerosis and other autoimmune conditions. The study was conducted by experts from Israel and Germany and appears in Autoimmunity Reviews.

Smell disorders (aka olfactory dysfunction) affect a significant number of people who have multiple sclerosis. A new study explains that olfactory dysfunction impacts the quality of life of MS patients and that a better understanding of this challenge could result in improved disease management.

The pomegranate is a challenging fruit with a tough rind, and it appears that fighting appearance harbors seeds with potential to battle multiple sclerosis. Researchers have found that pomegranate seed oil contains an extremely strong antioxidant that inhibited demyelination in a mouse model for MS.

On one level, the question as to whether chocolate can make multiple sclerosis fatigue better seems like a frivolous question. Doesn’t chocolate make lots of things better? Yet on a more serious note, researchers at Oxford Brookes University are planning to take a comprehensive look at the impact of chocolate on fatigue levels among individuals who live with MS.

Within several days of taking antiretroviral drugs to address possible HIV exposure, a 36-year-old woman with multiple sclerosis was able to get out of her wheelchair and walk again. This case and associated research highlight the question about the possible association between HIV and multiple sclerosis and the role of viral infections in causing this neurodegenerative disease.

Several female celebrities have embraced multiple sclerosis as a cause, each for her own reasons. Here’s a look at what three different well-known women have done to help advance knowledge, research, and treatment of multiple sclerosis.

Previous research has suggested that high cholesterol has a negative impact on the development of lesions in the brain of individuals with multiple sclerosis. Now a scientific team from the University of Buffalo has shed some light on how good cholesterol (high-density lipoprotein, or HDL cholesterol) may live up to its name for individuals who have this disease.

For multiple sclerosis patients who use Betaseron, the interferon beta-1b prescription drug designed to reduce relapses in individuals with relapsing-remitting MS, a new delivery system will be available soon in the United States. The Food and Drug Administration (FDA) has approved Bayer’s BetaConnect, the first electronic autoinjector for treating RRMS.

Jay Contrastano enjoyed playing golf, but when his multiple sclerosis took a turn for the worse, he thought his golfing days were over. That’s when he was introduced to an assistive device that changed his life for the better,